ICG & Management & Private Investors take majority stake in Domusvi
Context
ICG and founder Yves Journel have entered into exclusive negotiations to acquire the majority stake in DomusVi from PAI Partners. The transaction follows a preemptive bid by ICG that successfully bypassed a formal auction process involving major international investors and sovereign funds. This deal marks a significant change in scale for the group, which was valued at less than €650 million in 2014. The acquisition is structured to maintain the existing high-yield bond financing, as the continued presence of ICG and the founder in the capital prevents the activation of change-of-control repayment clauses. The strategic rationale centers on pursuing the international expansion of the group, particularly in markets like Spain, where the recent integration of SARquavitae has already propelled the company to a leadership position. The partnership intends to bridge the gap with major competitors such as Orpea and Korian-Medica by leveraging DomusVi's strong expertise in specialized care and home services.
Domusvi, which reported an EBITDA margin of [members only] in 2017, is valued in this transaction at an EV/EBITDA multiple of 10x–18x.
-> Deep-dive in Healthcare & Pharma market trends
Target
DomusVi stands as a leading international provider of high-quality elderly care and specialized services. The group operates an extensive cross-border network across Europe and Latin America, encompassing medicalized nursing homes, mental health facilities, and home care agencies. The entity actively executes a targeted buy-and-build strategy aimed at securing and strengthening its premier position within its domestic market. DomusVi’s value proposition is built upon a multi-disciplinary approach to dependency and senior care, seamlessly integrating medicalized residential care, specialized disability centers, and home assistance solutions to deliver a comprehensive support ecosystem for seniors and their families.
Ent. Value
€1–10bn
Equity Value
[members only]
Multiples
EV / Revenue
1x–3x
EV / EBITDA
10x–18x
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Domusvi
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 04/2021 | ICG / MANAGEMENT & PRIVATE INVESTORS | DOMUSVI | FRANCE | Nursing Homes |
| 03/2019 | DOMUSVI | RESIDALYA | FRANCE | Nursing Homes |
| 10/2016 | DOMUSVI | SARQUAVITAE | SPAIN | Nursing Homes |
| 06/2014 | PAI PARTNERS | DOMUSVI | FRANCE | Nursing Homes |
Other operations with ICG / Management & Private Investors
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 08/2018 | MANAGEMENT & PRIVATE INVESTORS | DESIGUAL | SPAIN | Fashion & Apparel |
| 07/2018 | MANAGEMENT & PRIVATE INVESTORS | BETJEMAN & BARTON | FRANCE | Coffee & Tea |
| 06/2017 | HG CAPITAL / GIC / MONTAGU PRIVATE EQUITY / ICG | VISMA GROUP | NORWAY | ERP, HR & Finance |
| 12/2016 | ICG | PARK HOLIDAYS | UNITED KINGDOM | Hospitality |
| 09/2015 | ICG | COURTEPAILLE | FRANCE | Restaurants / Chains |
| 06/2015 | ICG | STELLA | FRANCE | External Joinery |
| 02/2014 | ICG | APEM GROUP | FRANCE | Electrical Equipment |
| 07/2012 | MANAGEMENT & PRIVATE INVESTORS | LVL MEDICAL GERMANY | GERMANY | Outpatient Care |
| 03/2012 | MANAGEMENT & PRIVATE INVESTORS | ICELAND FOODS GROUP | UNITED KINGDOM | General Grocery |
| 02/2011 | ICG | GERFLOR | FRANCE | Flooring |
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 03/2018 | ICV PARTNERS | OUTPATIENT IMAGING AFFILIATES | UNITED STATES | Radiology |
| 01/2018 | PERMIRA | I-MED RADIOLOGY NETWORK | AUSTRALIA | Radiology |
| 05/2017 | BC PARTNERS | DENTALPRO | ITALY | Dental Centers |
| 04/2017 | EQT PARTNERS | COLISÉE | FRANCE | Nursing Homes |
| 01/2017 | MARS | VCA | UNITED STATES | Vet Clinics |
| 01/2017 | PARTNERS GROUP / PSP INVESTMENTS | CERBA HEALTHCARE | FRANCE | Labs (Biology) |
| 10/2016 | DOMUSVI | SARQUAVITAE | SPAIN | Nursing Homes |
| 05/2016 | VCA | COMPANION ANIMAL PRACTICES | UNITED STATES | Vet Clinics |
| 03/2016 | F2I SGR / CIR - COMPAGNIE INDUSTRIALI RIUNITE | KOS GROUP | ITALY | Nursing Homes |
| 02/2016 | OMERS | FOREFRONT DERMATOLOGY | UNITED STATES | Outpatient Care |
REFERENCES
Valuation range: EV €1–10bn
Revenue range: €1–10bn
EBITDA range: €100–200M
EV/Revenue range: 1x - 3x
EV/EBITDA range: 10x - 18x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Domusvi by ICG / Management & Private Investors are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
FAQ
What transaction does this page cover?
How was the acquisition of Domusvi by ICG valued, and what multiples were paid?
What were Domusvi’s revenue and EBITDA at the time of the deal?
What sources support the information on this transaction?
What is mynth?